Humankind Investments LLC Raises Stake in CVS Health Corporation $CVS

Humankind Investments LLC boosted its holdings in CVS Health Corporation (NYSE:CVS) by 95.7% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 22,753 shares of the pharmacy operator’s stock after buying an additional 11,126 shares during the period. Humankind Investments LLC’s holdings in CVS Health were worth $1,570,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of CVS. Avion Wealth raised its stake in shares of CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 189 shares during the period. Harbor Asset Planning Inc. purchased a new position in CVS Health in the second quarter valued at about $30,000. Bell Investment Advisors Inc lifted its stake in shares of CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 248 shares in the last quarter. Roxbury Financial LLC boosted its position in shares of CVS Health by 78.3% in the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 202 shares during the period. Finally, ORG Partners LLC grew its stake in shares of CVS Health by 418.9% in the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 377 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Stock Performance

Shares of CVS Health stock opened at $79.45 on Friday. The firm has a market cap of $100.85 billion, a PE ratio of 209.08, a price-to-earnings-growth ratio of 0.80 and a beta of 0.48. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $85.15. The firm’s 50-day simple moving average is $78.97 and its 200-day simple moving average is $71.83. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.24. The firm had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.CVS Health’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were paid a dividend of $0.665 per share. The ex-dividend date was Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.3%. CVS Health’s payout ratio is presently 700.00%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on CVS shares. TD Cowen boosted their price target on CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday. Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a research note on Wednesday. Jefferies Financial Group lifted their price target on shares of CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. Morgan Stanley upped their price objective on shares of CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $101.00 target price (up from $99.00) on shares of CVS Health in a research report on Wednesday. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $93.71.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.